TPO: Thyroid peroxidase
A drug works by acting on something in the body, usually a protein made by one gene. This is a page for each of those targets: the drugs that hit it and the diseases it is tied to.
Iodination and coupling of the hormonogenic tyrosines in thyroglobulin to yield the thyroid hormones T(3) and T(4). .
- Drugs that act on it: 3
- Approved: 3
- In phases 1 to 3: 0
- Sponsors: 2
Who Is On It, and How Far Along
Every drug ChEMBL records acting on TPO, by the furthest stage it has reached for any use, coloured by modality.
How to read this
Each mark is one drug. Columns run from approved to phase 1; hover or tap a mark for its sponsor, modality and open trials, and click it to open the drug.
- Small molecule
The Landscape
Every drug acting on it, furthest along first. The sponsor is the US application holder where there is one, else the industry lead sponsor of most of its registered trials. All act as: Thyroid peroxidase inhibitor.| Methimazole | Approved | Pfizer | Small molecule | Inhibitor | — | 7 | — |
| Carbimazole | Approved | — | Small molecule | Inhibitor | — | 1 | — |
| Propylthiouracil | Approved | PH Health | Small molecule | Inhibitor | — | 1 | Boxed warning |
Open Trials
The most recently posted recruiting or ongoing trials naming each drug (up to 8 a drug), 8 in all, from ClinicalTrials.gov.| AI-Based Wearable Monitoring (Glandy HYPER) for Antithyroid Drug Dose Adjustment in Graves' Disease | Methimazole | Not applicable | Not yet recruiting | THYROSCOPE INC. | 2026-10-05 |
| Impact of Vitamin D Therapy on Thyroid Function and Antibody Levels in Pediatric Graves' Disease | Methimazole | Phase 2 | Active, not recruiting | Northwell Health | 2026-01-27 |
| A Clinical Follow-up Study on Drug Therapy for Graves' Disease Patients in China | Methimazole | — | Recruiting | First Hospital of China Medical University | 2025-06-27 |
| Prospective Evaluation of OptiThyDose | Methimazole, Carbimazole | Not applicable | Recruiting | University Children's Hospital Basel | 2025-03-07 |
| Somesthesia in Cancer Patients: Variability and Influence on Eating Experience | Propylthiouracil | — | Not yet recruiting | Hospices Civils de Lyon | 2025-01-31 |
| A Clinical Study of Hyperthyroidism in Children | Methimazole | — | Recruiting | Shengjing Hospital | 2024-08-26 |
| Iodine Supplementation in Graves' Hyperthyroidism | Methimazole | Not applicable | Not yet recruiting | Shandong Provincial Hospital | 2024-08-06 |
| Effects of Different Treatment Schemes on the Regulation and Recurrence of Graves' Disease | Methimazole | Phase 4 | Recruiting | The First Affiliated Hospital with Nanjing Medical University | 2022-07-18 |
Diseases Most Associated With It
Open Targets association score, 0 to 1; all associations- Familial thyroid dyshormonogenesis
- 0.71
- Hypothyroidism
- 0.60
- Hyperthyroidism
- 0.59
- Thyroid gland disorder
- 0.56
- Hashimoto thyroiditis
- 0.55
- Congenital hypothyroidism
- 0.54
- Abnormality of the thyroid gland
- 0.53
- Nodular goiter
- 0.50
- Autoimmune thyroid disease
- 0.48
- Nontoxic goiter
- 0.44
- Myxedema
- 0.44
Drugs, mechanisms, furthest stage (max phase) and modality (molecule type) are from ChEMBL CHEMBL1839, ChEMBL 37, fetched 2026-11-18 (CC BY-SA 3.0). Sponsors are the US application holder (Drugs@FDA) for approved drugs with a US page, else the industry lead sponsor of the most of the drug's ClinicalTrials.gov trials. Open trials are recruiting or ongoing studies naming the drug as an intervention on ClinicalTrials.gov, checked daily; this page as of 2026-11-18. Gene name, function (UniProt P07202, CC BY 4.0) and disease associations are from Open Targets (CC0). ChEMBL and Open Targets